November 25, 2024 - 22:01

IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
February 9, 2026 - 01:49
Can AI Put The UK Back On The Map For Automotive Technology?The United Kingdom is leveraging its significant expertise in artificial intelligence to tackle complex challenges in automotive manufacturing, potentially reigniting its prominence in the global...
February 8, 2026 - 06:31
Regulating Digital Health TechnologiesThe rapid proliferation of digital health technologies, from AI-driven diagnostics to wellness apps, has ushered in a critical era for regulatory bodies worldwide. As noted by expert Randi Seigel,...
February 7, 2026 - 20:18
Student discusses how modern technology ruins sleep cyclesThe intricate and often detrimental relationship between modern technology and natural sleep patterns was the focus of a recent campus lecture. The presentation, titled “Broken Clocks: How...
February 7, 2026 - 05:07
How new AI technology is helping detect and prevent wildfiresAs wildfire seasons grow longer and more intense, a new wave of artificial intelligence technology is emerging as a critical tool in the early detection and prevention of catastrophic blazes....